Paltusotine not checked
Crinetics Pharmaceuticals Inc. · CRN00808
FollowEvery change as it happens, and a Monday email
Trials
1 active
6 in total · 4 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum, Carcinoid Tumor of Cecum, Carcinoid Tumor of Liver, Carcinoid Tumor of Pancreas, Carcinoid Syndrome Diarrhea and 1 more
- Main trialPhase 3
- “A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. The purpose of this study is to continue the evaluation of the safety, efficacy, and pharmacokinetics (PK) of paltusotine in participants with carcinoid syndrome.”In the company’s words, NCT07087054 on ClinicalTrials.gov
- Other names
- CRN00808
Other drugs for Carcinoid
- RYZ101RayzeBio, Inc. · Phase 3
- PembrolizumabMerck & Co. · Phase 2
- RYZ401RayzeBio, Inc. · Phase 1
Coming up1
- Aug 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | Aug 2027 | Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | |
| Phase 3Terminated | 10 Jul 2023 | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly | |
| Phase 3Terminated | 20 Jan 2024 | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) | |
| Phase 2Completed | 15 Jul 2020 | A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) | |
| Phase 2Completed | 3 Aug 2020 | An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) | |
| Phase 2Terminated | 30 Jun 2026 | A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026